Cargando…
YK-4-279 Attenuates Progression of Pre-Existing Pigmented Lesions to Nodular Melanoma in a Mouse Model
SIMPLE SUMMARY: Therapeutic options for melanoma are limited. In a prior study, we discovered the small molecule compound, YK-4-279, blocked tumor progression in a mouse model of melanoma. Tumor induction and drug administration occurred concurrently in this previous work. The aim of our current stu...
Autores principales: | Huang, Lee, Zhai, Yougang, Fajardo, Cristian D., Lang, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749984/ https://www.ncbi.nlm.nih.gov/pubmed/35008307 http://dx.doi.org/10.3390/cancers14010143 |
Ejemplares similares
-
The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer
por: Yu, Lin, et al.
Publicado: (2017) -
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
por: Barber-Rotenberg, Julie S., et al.
Publicado: (2012) -
YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
por: Rahim, Said, et al.
Publicado: (2011) -
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
por: Minas, Tsion Zewdu, et al.
Publicado: (2015) -
EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma
por: Sun, Wenjing, et al.
Publicado: (2017)